HomeXBIO • NASDAQ
add
Xenetic Biosciences Inc
Previous close
$2.45
Day range
$2.37 - $2.49
Year range
$2.20 - $13.93
Market cap
5.64M USD
Avg Volume
60.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.03M | 67.19% |
Operating expense | 1.57M | 41.12% |
Net income | -509.94K | -16.78% |
Net profit margin | -49.66 | 30.14% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.12M | -39.74% |
Total assets | 5.07M | -37.01% |
Total liabilities | 1.11M | 10.14% |
Total equity | 3.96M | — |
Shares outstanding | 2.29M | — |
Price to book | 0.96 | — |
Return on assets | -26.13% | — |
Return on capital | -32.40% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -509.94K | -16.78% |
Cash from operations | -658.25K | -43.40% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -658.25K | -43.40% |
Free cash flow | -488.77K | -46.10% |
About
Founded
1997
Headquarters
Website
Employees
2
